Paper3752979
Comparative in vitro evaluation of cefonicid, cefazolin, and penicillin against viridans group streptococci isolated from blood.
Weinstein MP. Antimicrob Agents Chemother, 1986. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Comparative in vitro evaluation of cefonicid, cefazolin, and penicillin against viridans group streptococci isolated from blood. Papers, record 3752979. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3752979
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparative in vitro evaluation of cefonicid, cefazolin, and penicillin against viridans group streptococci isolated from blood.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cefamandole | Major topic |
| Cefazolin | Major topic |
| Penicillins | Major topic |
| Sepsis | Major topic |
| Streptococcal Infections | Major topic |
| Streptococcus | Major topic |
| Cefonicid | |
| Endocarditis, Bacterial | |
| Humans | |
| Microbial Sensitivity Tests |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 96734 | SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/96734 | PubMed |
| 2 | 501146 | Antimicrobial susceptibilities of species of viridans streptococci. | J Infect Dis | 1979 | https://conductscience.org/library/papers/501146 | PubMed |
| 3 | 7054628 | Treatment of penicillin-sensitive streptococcal infective endocarditis. | Mayo Clin Proc | 1982 | https://conductscience.org/library/papers/7054628 | PubMed |
| 4 | 7102610 | Speciation of the "viridans" streptococci. | Am J Clin Pathol | 1982 | https://conductscience.org/library/papers/7102610 | PubMed |
| 5 | 6522927 | Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. | Rev Infect Dis | 1984 | https://conductscience.org/library/papers/6522927 | PubMed |
| 6 | 6601113 | Evaluation of the cefonicid disk test criteria, including disk quality control guidelines. | J Clin Microbiol | 1983 | https://conductscience.org/library/papers/6601113 | PubMed |
| 7 | 6511872 | Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus species. | J Clin Microbiol | 1984 | https://conductscience.org/library/papers/6511872 | PubMed |
| 8 | 6522920 | In vitro experience with cefonicid. | Rev Infect Dis | 1984 | https://conductscience.org/library/papers/6522920 | PubMed |
| 9 | 6828811 | The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. | Rev Infect Dis | 1983 | https://conductscience.org/library/papers/6828811 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3752979
GET https://conductscience.org/api/papers/v1/3752979/authors